S. Mohan Kumar, CEO & Director of Peerless Biotech Pvt. Ltd., in conversation with India Pharma Outlook, shares insights on how diagnostic innovation, particularly point-of-care and molecular diagnostics, is transforming healthcare delivery in India.
In an interaction with India Pharma Outlook, Nandakumar Kalathil, AVP Sales India at Agilent Technologies, discusses how high-resolution mass spectrometry is revolutionizing early disease detection in India by enhancing cancer biomarker sensitivity,
In an interaction with India Pharma Outlook, C. Mukundan, Managing Director, Atozeta Health Solutions, shared his valuable inputs on how AI-driven personalization and omnichannel scientific engagement are redefining pharma brand-building...
Ashok Kumar, President, Centre for Research and Development at Ipca Laboratories Limited, engages in an exclusive interaction with India Pharma Outlook, wherein he discussed how green chemistry is revolutionizing API production in India. In order to
In an interaction with India Pharma Outlook, Rajat Jain, GM – Global Sourcing Engineering & Capex, Panacea Biotec Ltd. shares his views on how Indian pharmaceutical companies are reengineering procurement strategies to balance regulatory compliance
In an exclusive interaction with India Pharma Outlook, Chandra Ganjoo, Group CEO of Trivitron Healthcare, discusses how MedTech in India is advancing healthcare through AI-driven diagnostics, local manufacturing, and policy support...